[PDF][PDF] ORALE ANTITUMORALE GENEESMIDDELEN BIJ HEMATOLOGISCHE AANDOENINGEN EN THERAPIETROUW: BELANG, EVALUATIE EN …

C VAN POUCKE - libstore.ugent.be
Inleiding: De opkomst van de orale doelgerichte antitumorale therapie brengt een aantal
voor-en nadelen met zich mee. De patiënt krijgt zijn medicatie niet langer intraveneus …

[PDF][PDF] RESEARCH ARTICLE AJH AJH

R Curtis, J Baker, B Riske, M Ullman… - American Journal of …, 2015 - researchgate.net
Historically, bleeding due to hemophilia is characterized primarily by joint bleeding leading
to joint arthritis and pain. Infectious diseases also have posed significant morbidity and …

[PDF][PDF] Possible involvement of tyrosine kinase inhibitors on the expression of CXCR4 in chronic myeloid leukemia

TC Fujita, GAF Vitiello, MK Amarante, CEC de Oliveira… - academia.edu
Purpose: Chronic myeloid leukemia (CML) treatment has improved significantly in the last
decade with the introduction of tyrosine kinase inhibitors (TKIs), which target BCR/ABL …

Benzo [e] pryridoindolones, nouveaux inhibiteurs de kinases hydrosolubles à fort potentiel anti-prolifératif

LTT Le - 2013 - theses.hal.science
Nous étudions une nouvelles familles d'inhibiteurs de kinase: les benzopyridoindole. Ces
molécules ont des effets antiprolifératifs sur des lignées cancéreuses et représentent les …

New mutation L324M in the ABL1 kinase domain: does it confer high resistance to second-generation inhibitors?

MF Noriega, CA Ferri, G Icardi, E Bullorsky… - Leukemia & …, 2014 - Taylor & Francis
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of pluripotent
hematopoietic stem cells characterized by the presence of the Philadelphia chromosome …

[PDF][PDF] Chronic Myeloid Leukemia–From the National to the European Registry–Limited Experience of a Single Center

AM Vlădăreanu, I Voican, H Bumbea, D Vasile… - ROM. J. INTERN …, 2010 - academia.edu
The better understanding of the CML biology provided by the latest researches requires a
deeper knowledge about the epidemiologic data in each geographic area, so the compiling …

[图书][B] Active transport and CNS delivery of novel tyrosine kinase inhibitors

Y Chen - 2009 - search.proquest.com
Tyrosine kinase inhibitors (TKIs) are promising agents for specific inhibition of malignant cell
growth and metastasis formation. They directly interfere with TK enzymes that are activated …

Design of Novel Anticancer Drugs Utilizing Busulfan for Optimizing Pharmacological Properties and Pattern Recognition Techniques for Elucidation of Clinical Efficacy

R Bartzatt - 2009 - digitalcommons.unomaha.edu
Chronic myelogenous leukemia (CML) is a disorder in which an excessive number of blood
stem cells develop into the white blood cell group called granulocytes. The anticancer drug …

Potential treatment algorithms and future directions for patients with chronic myeloid leukemia

TI Mughal, JM Goldman - Chronic Myeloproliferative Disorders, 2013 - taylorfrancis.com
Since the introduction of imatinib mesylate, the 'first generation'tyrosine kinase inhibitor
(TKI), into the clinic in 1998, the drug has become the preferred treatment for the majority, if …

Leukaemias

TI Mughal, JM Goldman - Treatment of Cancer, 2008 - taylorfrancis.com
Leukaemias comprise a heterogeneous group of clonal disorders of haemopoiesis, affecting
both haemopoietic stem cells and progenitor cells within the myeloid and lymphocytic …